Literature DB >> 18116849

Southwest Pacific vivax malaria; clinical features and observations concerning duration of clinical activity.

E HILL, D S AMATUZIO.   

Abstract

Entities:  

Keywords:  MALARIA

Mesh：

Year:  1949        PMID： 18116849

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN： 0002-9637            Impact factor:   2.345


× No keyword cloud information.
  10 in total

Review 1.  8-Aminoquinoline Therapy for Latent Malaria.

Authors:  J Kevin Baird
Journal:  Clin Microbiol Rev       Date:  2019-07-31       Impact factor: 26.132

Review 2.  Strain theory of malaria: the first 50 years.

Authors:  F Ellis McKenzie; David L Smith; Wendy P O'Meara; Eleanor M Riley
Journal:  Adv Parasitol       Date:  2008       Impact factor: 3.870

Review 3.  The anaemia of Plasmodium vivax malaria.

Authors:  Nicholas M Douglas; Nicholas M Anstey; Pierre A Buffet; Jeanne R Poespoprodjo; Tsin W Yeo; Nicholas J White; Ric N Price
Journal:  Malar J       Date:  2012-04-27       Impact factor: 2.979

4.  Radical cure: the case for anti-relapse therapy against all malarias.

Authors:  J Kevin Baird
Journal:  Clin Infect Dis       Date:  2011-03-01       Impact factor: 9.079

Review 5.  Determinants of relapse periodicity in Plasmodium vivax malaria.

Authors:  Nicholas J White
Journal:  Malar J       Date:  2011-10-11       Impact factor: 2.979

6.  Epidemiology of Plasmodium vivax in Indonesia.

Authors:  Claudia Surjadjaja; Asik Surya; J Kevin Baird
Journal:  Am J Trop Med Hyg       Date:  2016-10-05       Impact factor: 2.345

Review 7.  Methaemoglobinaemia and the radical curative efficacy of 8-aminoquinoline antimalarials.

Authors:  Nicholas J White; James A Watson; J Kevin Baird
Journal:  Br J Clin Pharmacol       Date:  2022-01-27       Impact factor: 3.716

Review 8.  Anti-malarial drug effects on parasite dynamics in vivax malaria.

Authors:  Nicholas J White
Journal:  Malar J       Date:  2021-03-21       Impact factor: 2.979

9.  Gametocyte dynamics and the role of drugs in reducing the transmission potential of Plasmodium vivax.

Authors:  Nicholas M Douglas; Julie A Simpson; Aung Pyae Phyo; Hadjar Siswantoro; Armedy R Hasugian; Enny Kenangalem; Jeanne Rini Poespoprodjo; Pratap Singhasivanon; Nicholas M Anstey; Nicholas J White; Emiliana Tjitra; Francois Nosten; Ric N Price
Journal:  J Infect Dis       Date:  2013-06-12       Impact factor: 5.226

10.  Point-of-care G6PD diagnostics for Plasmodium vivax malaria is a clinical and public health urgency.

Authors:  J Kevin Baird
Journal:  BMC Med       Date:  2015-12-14       Impact factor: 8.775
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.